[HTML][HTML] Sodium-Glucose Cotransporter 2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis: The Other Side of the Coin!
SD Kamath, U Kumar, V Shrivastava - Cureus, 2024 - ncbi.nlm.nih.gov
Euglycemic diabetic ketoacidosis (EDKA) though rare is a life-threatening complication of
sodium-glucose cotransporter 2 (SGLT2) inhibitors. With their increasing use in the …
sodium-glucose cotransporter 2 (SGLT2) inhibitors. With their increasing use in the …
Euglycemic diabetes ketoacidosis associated with SGLT-2 inhibitors-review of case reports
J Winciorek, P Cyran, A Jaroszyńska… - Journal of Education …, 2024 - apcz.umk.pl
AIM: Sodium-glucose cotransporter 2 (SGLT-2) inhibitors have gained significant importance
in the treatment of type 2 diabetes mellitus. One of the adverse effects while using SGLT-2 …
in the treatment of type 2 diabetes mellitus. One of the adverse effects while using SGLT-2 …
Pharmaceutical care for a patient with empagliflozin-induced euglycemic diabetic ketoacidosis
Y Lili, LI Qi, W Hui, GAO Ruilong… - China …, 2025 - journal.china-pharmacy.com
OBJECTIVETo provide a reference for the pharmaceutical care of a patient with type 2
diabetes mellitus (T2DM) and limb-girdle muscular dystrophy (LGMD) who developed …
diabetes mellitus (T2DM) and limb-girdle muscular dystrophy (LGMD) who developed …
[引用][C] Side effects of medications used in the management of diabetes
MS D'Souza, H Salamie, M Krmic, B Slezak, SD Ray - 2024 - Elsevier